# Autologous Polyclonal Tregs for Lupus

> **NCT02428309** · PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1 (actual)

## Conditions studied

- Lupus Erythematosus, Cutaneous
- Lupus Erythematosus, Discoid
- Lupus Erythematosus, Systemic

## Interventions

- **BIOLOGICAL:** Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells

## Key facts

- **NCT ID:** NCT02428309
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08-27
- **Primary completion:** 2016-09-02
- **Final completion:** 2018-10-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Due to participant recruitment feasibility
- **Last updated:** 2019-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02428309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02428309, "Autologous Polyclonal Tregs for Lupus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02428309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*